Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-29

Clinical Trial Update: Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule

View source ↗

Summary

A multicenter, open, prospective observational study evaluating the safety and efficacy of Nephoxil Capsule for hyperphosphatemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nephoxil Capsule

Snippet

Sponsor: Kyowa Kirin Korea Co., Ltd. | Conditions: Hyperphosphatemia | Status: RECRUITING